| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 45 | 25.254 | 51.048 | 74.781 |
| Total Income - EUR | - | - | - | - | - | - | 45 | 25.254 | 51.048 | 74.782 |
| Total Expenses - EUR | - | - | - | - | - | - | 147 | 1.625 | 14.284 | 55.558 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -102 | 23.629 | 36.764 | 19.224 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -103 | 23.379 | 36.269 | 17.311 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ergasia Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 1.769 | 52.768 |
| Current Assets | - | - | - | - | - | - | 78 | 5.326 | 23.586 | 22.256 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 2.382 | 10.340 | 13.380 |
| Cash | - | - | - | - | - | - | 78 | 2.944 | 13.246 | 8.876 |
| Shareholders Funds | - | - | - | - | - | - | -63 | 4.106 | 23.068 | 25.399 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 140 | 1.220 | 2.287 | 49.630 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ergasia Med S.r.l.